SRGN and plasma cell myeloma: The glycoaminoglycan chains vary depending on cell type and have an important impact on serglycin function.10 Although serglycin does not contain a transmembrane domain, it can be constitutively secreted by hematopoietic cells, endothelial cells, pancreatic acinar cells and myeloma cells.9, 11, 12, 13